NPHCDA Immunization FHIR IG, published by https://nphcda.gov.ng. This guide is not an authorized publication; it is the continuous build for version 0.7.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/Nigeria-FHIR-Community/NPHCDA-ImmunizationIG/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: Example NG-Imm Allergy Intolerance 001 - XML Representation

Raw xml | Download

<AllergyIntolerance xmlns="http://hl7.org/fhir">
  <id value="allergyIntolerance-002"/>
  <meta>
    <profile
             value="https://nphcda.gov.ng/ig/StructureDefinition/allergy-intolerance-profile"/>
  </meta>
  <text>
    <status value="extensions"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: AllergyIntolerance allergyIntolerance-002</b></p><a name="allergyIntolerance-002"> </a><a name="hcallergyIntolerance-002"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-allergy-intolerance-profile.html">NG-Imm AllergyIntolerance</a></p></div><p><b>NG-Imm Allergy Dose Number</b>: 457</p><p><b>NG-Imm Dose Series</b>: Measles Infant Series</p><p><b>clinicalStatus</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical resolved}">Resolved</span></p><p><b>verificationStatus</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/allergyintolerance-verification confirmed}">Confirmed</span></p><p><b>type</b>: Allergy</p><p><b>category</b>: Medication, Biologic</p><p><b>criticality</b>: Low Risk</p><p><b>code</b>: <span title="Codes:{http://snomed.info/sct 871817003}">Measles morbillivirus and Rubella virus antigens only vaccine product</span></p><p><b>patient</b>: <a href="Patient-patient-003.html">Tolu Oluwatobi Adeyemi  Male, DoB: 2022-09-21 ( MRN)</a></p><p><b>encounter</b>: <a href="Encounter-encounter-002.html">Encounter: extension = ; status = finished; class = PHC Center Level 2 (IMMZ.D.DE3 Facility Type CS#phc-center-l2)</a></p><p><b>onset</b>: 2025-07-20 10:45:00+0100</p><p><b>recordedDate</b>: 2025-07-20 11:30:00+0100</p><p><b>recorder</b>: <a href="Practitioner-practitioner-002.html">Practitioner Musa Abdullahi </a></p><p><b>lastOccurrence</b>: 2025-07-21 08:00:00+0100</p><blockquote><p><b>reaction</b></p><p><b>substance</b>: <span title="Codes:{http://snomed.info/sct 871765008}">Measles vaccine</span></p><p><b>manifestation</b>: <span title="Codes:{http://snomed.info/sct 386661006}">Fever</span>, <span title="Codes:{http://snomed.info/sct 247471006}">Maculopapular rash</span></p><p><b>description</b>: Fever (38.5 °C) and rash developed within 24 hours after measles vaccine.</p><p><b>onset</b>: 2025-07-20 18:00:00+0100</p><p><b>severity</b>: Mild</p></blockquote></div>
  </text>
  <extension
             url="https://nphcda.gov.ng/ig/StructureDefinition/allergy-reference-dose-number">
    <valueInteger value="457"/>
  </extension>
  <extension
             url="https://nphcda.gov.ng/ig/StructureDefinition/allergy-reference-dose-series">
    <valueString value="Measles Infant Series"/>
  </extension>
  <clinicalStatus>
    <coding>
      <system
              value="http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical"/>
      <code value="resolved"/>
      <display value="Resolved"/>
    </coding>
  </clinicalStatus>
  <verificationStatus>
    <coding>
      <system
              value="http://terminology.hl7.org/CodeSystem/allergyintolerance-verification"/>
      <code value="confirmed"/>
      <display value="Confirmed"/>
    </coding>
  </verificationStatus>
  <type value="allergy"/>
  <category value="medication"/>
  <category value="biologic"/>
  <criticality value="low"/>
  <code>
    <coding>
      <system value="http://snomed.info/sct"/>
      <code value="871817003"/>
      <display
               value="Measles morbillivirus and Rubella virus antigens only vaccine product"/>
    </coding>
  </code>
  <patient>🔗 
    <reference value="Patient/patient-003"/>
  </patient>
  <encounter>🔗 
    <reference value="Encounter/encounter-002"/>
  </encounter>
  <onsetDateTime value="2025-07-20T10:45:00+01:00"/>
  <recordedDate value="2025-07-20T11:30:00+01:00"/>
  <recorder>🔗 
    <reference value="Practitioner/practitioner-002"/>
  </recorder>
  <lastOccurrence value="2025-07-21T08:00:00+01:00"/>
  <reaction>
    <substance>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="871765008"/>
        <display value="Measles vaccine"/>
      </coding>
    </substance>
    <manifestation>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="386661006"/>
        <display value="Fever"/>
      </coding>
    </manifestation>
    <manifestation>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="247471006"/>
        <display value="Maculopapular rash"/>
      </coding>
    </manifestation>
    <description
                 value="Fever (38.5 °C) and rash developed within 24 hours after measles vaccine."/>
    <onset value="2025-07-20T18:00:00+01:00"/>
    <severity value="mild"/>
  </reaction>
</AllergyIntolerance>